| Autor: |
Masakazu Komoriya, MD, Shinobu Imai, MD, Hiroshi Aoyama, MD, Hideki Yagi, MD, Masaaki Nagashima, MD, Mitsunobu Enomoto, MD, Kazutaka Suzuki, MD, Satoshi Yamaji, MD, Hidehito Takase, MD, Kagari Matsudaira, MD, Naoyuki Takahashi, MD, Fumio Saito, MD, Hiroshi Yagi, MD, Toshio Kushiro, MD, Ken Nagao, MD, Atsushi Hirayama, MD |
| Jazyk: |
angličtina |
| Rok vydání: |
2008 |
| Předmět: |
|
| Zdroj: |
Journal of Arrhythmia, Vol 24, Iss 1, Pp 18-25 (2008) |
| Druh dokumentu: |
article |
| ISSN: |
1880-4276 |
| DOI: |
10.1016/S1880-4276(08)80003-8 |
| Popis: |
There are few long-term reports of patients with frequent PVCs in the absence of ischemic heart disease. In 86 patients without ischemic heart disease, who had 1000 or more PVCs in 24-hour Holter ECG, the number of PVCs during 24-hours Holter ECG and echocardiographic parameters were followed at least 1 year (66.5 ± 39.7 months). PVC was significantly reduced in the patients with or without underlying diseases (UD). The reduction rate in the number of PVCs was prominent in patients with UD. PVC was significantly reduced in patients under medication, but not in patients without medication. In the comparison between the initial and follow up observation using Wilcoxon's rank test, the number of PVC was significantly reduced (P < 0.05), and EF was also improved (P < 0.05) in angiotensin converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) group, and in β-blocker group. In Ca-antagonist group and antiarrhythmic drug group, the number of PVCs was also significantly reduced (P < 0.05). Multivariate analysis revealed significantly higher incidence (60% or more with PVC reduction) in ACEI/ARB group. These results suggest that the administration of ACEI/ARB may contribute to the reduction of PVC in non-ischemic heart disease cases with multiple PVC. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
Plný text